The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

Share Price Information for Argentex Group. (AGFX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.00
Bid: 34.00
Ask: 34.90
Change: -0.40 (-1.16%)
Spread: 0.90 (2.647%)
Open: 34.00
High: 34.00
Low: 34.00
Prev. Close: 34.40
AGFX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and CFO appointment

30 Jan 2024 07:00

RNS Number : 2835B
Argentex Group PLC
30 January 2024
 

30 January 2024

 

Argentex Group PLC

 

("Argentex" or the "Group")

 

Trading Update

Appointment of Interim CFO

 

 

Argentex Group PLC (AIM: AGFX), the provider of currency management and payment solutions to international institutions and corporates, today issues a trading update for the year ended 31 December 2023 and announces the appointment of an Interim CFO.

Trading Update

On 10 November 2023 Argentex announced that it expected to report that revenue and operating profit for the 12 months to 31 December 2023 would be at approximately the same levels as for the twelve months ended 31 December 2022.

The Board now confirms that it expects revenues for the twelve months to 31 December 2023 of approximately £49.8m, compared to £50.4m for the twelve months to 31 December 2022*, and operating profit of not less than £8.0m, compared with £11.3m for the same period in 2022.

The Group invested, as communicated at the time, for growth in 2023, with significant investment in people, technology and overseas expansion. However, market conditions have remained challenging and there have been a number of costs which had not been anticipated previously.

*the Group changed to a 31 December year end reporting date in FY2022 and published audited results for a 9 month period to 31 December 2022. FY2023 results have been compared with an equivalent 12-month period for 2022.

 

Appointment of Interim CFO

Argentex is pleased to announce the appointment of Guy Rudolph as Interim Chief Financial Officer with effect from 31 January 2024. Guy is a qualified chartered accountant and began his career at PwC before joining Vodafone where he spent 16 years driving transformation across international teams in his roles as Group Audit and Risk Director, and Director of Group Financial Operations. He was also the deputy CFO of Camelot from 2017 to 2022 and later interim Director of Group Finance at Rank Group plc.

 

Jim Ormonde, Interim CEO of Argentex, commented: 

 

"The results for 2023 are clearly below market expectations but we remain confident that there is a significant market opportunity for us to exploit. We will share our plans for the business with investors following the publication of our full year results in April and after we have completed our strategic review.

The Group continues to be profitable and highly cash generative, with a new senior management team fully focused on transforming the business to capitalise on the growth opportunities ahead. We will be looking for operational efficiencies in addition to sustainable growth and Guy's rigour will strengthen our forecasting capability and help drive cost discipline and accountability across the management team. 

We are positive about the long-term outlook of Argentex and look forward to sharing the outcomes from the ongoing strategic review following the full year results in April." 

 

This announcement contains inside information for the purposes of the UK version of the Market Abuse Regulation ("MAR") which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018; as amended. Upon publication of this announcement, the inside information is now considered to be in the public domain for the purposes of MAR.

 

For further information, please contact:

 

Argentex Group PLC

Jim Ormonde - Interim Chief Executive Officer

investorrelations@argentex.com

Singer Capital Markets (Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / Angus Campbell

020 7496 3000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTQKCBQFBKDQDB
Date   Source Headline
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update
26th Feb 20212:58 pmRNSDirector/PDMR Shareholding
17th Feb 20213:12 pmRNSHolding(s) in Company
9th Feb 20212:34 pmRNSHolding(s) in Company
20th Jan 20217:00 amRNSTrading update and Board changes
20th Nov 20207:00 amRNSInterim Results
19th Nov 20204:53 pmRNSHolding(s) in Company
4th Nov 20207:00 amRNSNotice of interim results
12th Oct 20207:00 amRNSDirector Declaration
12th Oct 20207:00 amRNSTrading Statement
6th Oct 20204:40 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
30th Sep 20204:40 pmRNSSecond Price Monitoring Extn
30th Sep 20204:35 pmRNSPrice Monitoring Extension
21st Sep 20205:50 pmRNSChange of Registered Office
11th Sep 20202:18 pmRNSAGM Statement
7th Sep 20204:36 pmRNSPrice Monitoring Extension
10th Aug 20207:17 amRNSAnnual Report and Notice of Annual General Meeting
3rd Aug 20207:00 amRNSFull year results for period ending 31 March 2020
29th Jul 20204:35 pmRNSPrice Monitoring Extension
9th Jul 20207:00 amRNSNotice of Full Year Results
8th Jul 20205:24 pmRNSHolding(s) in Company
29th Jun 20209:11 amRNSHolding(s) in Company
27th May 20207:00 amRNSArgentex Group announces new headquarters
26th May 20204:40 pmRNSSecond Price Monitoring Extn
26th May 20204:35 pmRNSPrice Monitoring Extension
8th Apr 20207:00 amRNSDirector/PDMR Shareholding
1st Apr 20205:40 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSTrading Update
27th Mar 20204:41 pmRNSSecond Price Monitoring Extn
27th Mar 20204:36 pmRNSPrice Monitoring Extension
25th Mar 20204:00 pmRNSDirector/PDMR Shareholding
18th Mar 202011:46 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.